Drug intelligence / Profile preview

heat shock protein 70 small interfering RNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

Heat shock protein 70 small interfering RNA (HSP70 siRNA) is an RNA-based therapeutic approach designed to silence the expression of the HSPA1A gene, which encodes the major stress-inducible chaperone protein HSP70. HSP70 is frequently overexpressed in various malignancies, including hepatocellular carcinoma (HCC), where it facilitates protein folding, prevents apoptosis, and promotes tumor cell proliferation, migration, and metastasis. By utilizing the RNA interference (RNAi) pathway, the siRNA mediates the sequence-specific degradation of HSP70 mRNA. This downregulation leads to cell cycle arrest at the G1/S transition—often associated with the upregulation of p27Kip1 and downregulation of cyclin D1—thereby inhibiting the growth and invasive potential of cancer cells. While primarily used as a research tool to validate HSP70 as a therapeutic target, siRNA-mediated knockdown of HSP70 represents a potential strategy for precision oncology.

Other names
HSP70 siRNAHSP-70 siRNAHSP 70 siRNAsiRNA-HSP70siRNA-HSP-70siRNA-HSP 70HSPA1A siRNAHSPA-1A siRNAHSPA 1A siRNAheat shock protein 70 siRNA
02

Targets

HSPA1A (HSP70-1A)

Beyond the preview

Go deeper on heat shock protein 70 small interfering RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on heat shock protein 70 small interfering RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call